Tower Research Capital LLC (Trc) Ovid Therapeutics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,840 shares of OVID stock, worth $5,215. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,840
Previous 8,301
18.54%
Holding current value
$5,215
Previous $9,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding OVID
# of Institutions
82Shares Held
40.7MCall Options Held
2.4KPut Options Held
200-
Rubric Capital Management LP New York, NY5.32MShares$2.82 Million0.08% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$2.12 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.04 Million0.13% of portfolio
-
Madison Avenue Partners, LP New York, NY3.72MShares$1.97 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.15MShares$1.67 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $37.3M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...